Pharsight

Drugs that contain Escitalopram Oxalate

1. Lexapro patents expiration

LEXAPRO's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6916941 ALLERGAN Crystalline composition containing escitalopram
Aug, 2022

(1 year, 6 months ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7420069 ALLERGAN Crystalline composition containing escitalopram
Aug, 2022

(1 year, 6 months ago)

US6916941

(Pediatric)

ALLERGAN Crystalline composition containing escitalopram
Feb, 2023

(1 year, 12 days ago)

US7420069

(Pediatric)

ALLERGAN Crystalline composition containing escitalopram
Feb, 2023

(1 year, 12 days ago)

Drug Exclusivity Drug Exclusivity Expiration
New Patient Population (NPP) May 12, 2026

Market Authorisation Date: 14 August, 2002

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of LEXAPRO before it's drug patent expiration?
More Information on Dosage

LEXAPRO family patents

Family Patents